Dow Up0.07% Nasdaq Up0.61%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
48.20 Up 0.75(1.58%) 4:00PM EST
|After Hours : 48.19 Down 0.01 (0.02%) 4:56PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue -   -   13,625   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   13,625   -  
Operating Expenses
Research Development34,965  28,440  24,151  22,544  
Selling General and Administrative6,155  6,126  6,142  5,950  
Non Recurring -  400  8,406   -  
Others -   -  3,409   -  
Total Operating Expenses -   -  42,108   -  
Operating Income or Loss (41,120) (34,966) (28,483) (28,494)
Income from Continuing Operations
Total Other Income/Expenses Net1,770  270  (106)(657)
Earnings Before Interest And Taxes(39,350)(34,696)(28,589)(29,151)
Interest Expense -   -   -   -  
Income Before Tax(39,350)(34,696)(28,589)(29,151)
Income Tax Expense292  68  2,129  52  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(39,642)(34,764)(30,718)(29,203)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (39,642) (34,764) (30,718) (29,203)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (39,642) (34,764) (30,718) (29,203)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.